Plenful Competitive Intelligence & Landscape

Yutori’s Scouts highlights that Plenful’s market remains relatively quiet compared to competitors advancing in diagnostics and clinical validation, indicating a possible gap in market penetration or product maturity (scouts.yutori.com). Meanwhile, Fuelfinance offers financial management and planning tools, positioning itself as a competitor in enterprise management solutions, though more finance-focused than healthcare-specific (fuelfinance.me).

In terms of market share and revenue, Plenful’s estimated annual revenue is around $13.6 million with a growing employee base, indicating a competitive position in healthcare automation. Its recent funding of $76 million supports aggressive growth, but it still trails behind larger healthcare providers and enterprise automation platforms that serve broader industries (growjo).

Overall, Plenful’s main competitors include specialized workflow automation platforms like Process Street, traditional healthcare providers, and enterprise financial management solutions. While it aims to carve out a niche in healthcare automation, its market share remains modest compared to larger, more established players in healthcare services and enterprise software (canvasbusinessmodel.com).

Tim L'Hommedieu is a notable executive at Plenful, holding the position of Senior Vice President of Pharmacy since May 2025. His extensive background in pharmacy leadership and healthcare innovation suggests a significant role in the company's strategic operations, particularly in pharmacy and clinical services (Result 1).

While specific details about board members or recent high-level hires are not explicitly mentioned in the available sources, Plenful's recent funding round of $50 million in June 2025, led by prominent investors like Mitchell Rales and Arena Holdings, indicates ongoing growth and potential leadership expansion to support its scaling efforts (Result 5). Overall, the leadership appears focused on advancing healthcare automation through strategic executive roles and significant investment.

Plenful's platform handles a variety of functions, including 340B audits, processing referrals and intake forms, optimizing contracted rates, and managing pharmacy claims auditing. It is built to integrate with various data sources, including Electronic Health Records (EHRs), Pharmacy Management Systems, and electronic prior authorization (ePA) systems, and can process diverse data formats, from faxes to electronic data files (Plenful, Plenful).

The company has established relationships with numerous leading healthcare organizations. Notable enterprise clients include the Medical University of South Carolina (MUSC), Cencora, Renown Health, Shields Healthcare Group, and Samaritan Health, among others.

Plenful also highlights its work with BioMatrix Specialty Infusion Pharmacy and UofL Health. These partnerships underscore Plenful's role in enhancing operational efficiency across a broad spectrum of healthcare providers (Notable Capital, Plenful, Plenful).

Plenful has secured significant funding to fuel its growth and platform development, including a $50 million Series B round in April 2025, co-led by Mitchell Rales and Arena Holdings, with participation from investors such as Notable Capital, Bessemer Venture Partners, and TQ Ventures. This funding has enabled Plenful to expand its AI-powered automation capabilities, particularly in areas like intake and prior authorization, aiming to accelerate patient care and reduce administrative burdens by up to 75% (PRNewswire, MobiHealthNews). The company's technology integrates with disparate data sources, including EHRs and Pharmacy Management Systems, to create a more cohesive operational workflow (Plenful).